Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid

Journal of Bacteriology

Volumn 192, Issue 19, 2010, Pages 4983-4990

  Sorg, Joseph A ^a   Sonenshein, Abraham L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHENODEOXYCHOLIC ACID; CHENODEOXYCHOLIC ACID DERIVATIVE; TAUROCHOLIC ACID; BILE ACID; DRUG DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; HYDROXYLATION; INTESTINE FLORA; KINETICS; MICHAELIS MENTEN KINETICS; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SPORE GERMINATION; BACTERIAL SPORE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM SCINDENS;

BILE ACIDS AND SALTS; CHENODEOXYCHOLIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOSTRIDIUM DIFFICILE; SPORES, BACTERIAL; TAUROCHOLIC ACID;

EID: 77957337708     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00610-10     Document Type: Article

References (54)

1. Akoachere, M., R. C. Squires, A. M. Nour, L. Angelov, J. Brojatsch, and E. Abel-Santos. 2007. Identification of an in vivo inhibitor of Bacillus anthracis spore germination. J. Biol. Chem. 282:12112-12118.
2. Batta, A. K., G. Salen, R. Arora, S. Shefer, M. Batta, and A. Person. 1990. Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J. Biol. Chem. 265:10925-10928.
3. Bliss, D. Z., S. Johnson, C. R. Clabots, K. Savik, and D. N. Gerding. 1997. Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients. Diagn. Microbiol. Infect. Dis. 29:1-4.
4. Capaldi, S., G. Saccomani, D. Fessas, M. Signorelli, M. Perduca, and H. L. Monaco. 2009. The x-ray structure of zebrafish (Danio rerio) ileal bile acid-binding protein reveals the presence of binding sites on the surface of the protein molecule. J. Mol. Biol. 385:99-116.
5. Coleman, J. P., W. B. White, and P. B. Hylemon. 1987. Molecular cloning of bile acid 7-dehydroxylase from Eubacterium sp. strain VPI 12708. J. Bacteriol. 169:1516-1521.
6. Dawson, A. M., D. Trenchard, and A. Guz. 1965. Small bowel tonometry: assessment of small gut mucosal oxygen tension in dog and man. Nature 206:943-944.
7. Dawson, J. A., D. H. Mallonee, I. Bjorkhem, and P. B. Hylemon. 1996. Expression and characterization of a C24 bile acid 7 alpha-dehydratase from Eubacterium sp. strain VPI 12708 in Escherichia coli. J. Lipid Res. 37:1258-1267.
8. Dubberke, E. R., K. A. Reske, M. A. Olsen, L. C. McDonald, and V. J. Fraser. 2008. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin. Infect. Dis. 46:497-504.
9. Ghantoji, S. S., K. Sail, D. R. Lairson, H. L. DuPont, and K. W. Garey. 2010. Economic healthcare costs of Clostridium difficile infection: a systematic review. J. Hosp. Infect. 74:309-318.
10. Giel, J. L., J. A. Sorg, A. L. Sonenshein, and J. Zhu. 2010. Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One 5:e8740.
11. Goodwin, B., and S. A. Kliewer. 2002. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G926-931.
12. Jump, R. L. P., M. J. Pultz, and C. J. Donskey. 2007. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob. Agents Chemother. 51:2883-2887.
13. Kamiya, S., K. Yamakawa, H. Ogura, and S. Nakamura. 1989. Recovery of spores of Clostridium difficile altered by heat or alkali. J. Med. Microbiol. 28:217-221.
14. Karas, J. A., D. A. Enoch, and S. H. Aliyu. A review of mortality due to Clostridium difficile infection. J. Infect. doi:10.1016/j.jinf.2010.03.025.
15. Kuijper, E. J., J. T. van Dissel, and M. H. Wilcox. 2007. Clostridium difficile: changing epidemiology and new treatment options. Curr. Opin. Infect. Dis. 20:376-383.
16. Kyne, L., M. B. Hamel, R. Polavaram, and C. P. Kelly. 2002. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34:346-353.
17. Lawley, T. D., N. J. Croucher, L. Yu, S. Clare, M. Sebaihia, D. Goulding, D. J. Pickard, J. Parkhill, J. Choudhary, and G. Dougan. 2009. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J. Bacteriol. 191:5377-5386.
18. Lyras, D., J. R. O'Connor, P. M. Howarth, S. P. Sambol, G. P. Carter, T. Phumoonna, R. Poon, V. Adams, G. Vedantam, S. Johnson, D. N. Gerding, and J. I. Rood. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature doi:10.1038/nature07822.
19. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science 284:1362-1365.
20. Mallonee, D. H., J. L. Adams, and P. B. Hylemon. 1992. The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase. J. Bacteriol. 174:2065-2071.
21. Mallonee, D. H., and P. B. Hylemon. 1996. Sequencing and expression of a gene encoding a bile acid transporter from Eubacterium sp. strain VPI 12708. J. Bacteriol. 178:7053-7058.
22. Mara, G., R. Domenico, A. Michael, Z. Serena, P. Patrizia, R. Laura, T. Anna, and M. Henriette. 2008. Identification and functional characterization of the bile acid transport proteins in nonmammalian ileum and mammalian liver. Proteins 70:462-472.
23. Martinez-Augustin, O., and F. Sanchez de Medina. 2008. Intestinal bile acid physiology and pathophysiology. World J. Gastroenterol. 14:5630-5640.
24. McFarland, L. 2008. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat. Clin. Pract. Gstroentrol. Hepatol. 5:40-48.
25. Mekhjian, H. S., S. F. Phillips, and A. F. Hofmann. 1979. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig. Dis. Sci. 24:545-550.
26. Mi, L.-Z., S. Devarakonda, J. M. Harp, Q. Han, R. Pellicciari, T. M. Willson, S. Khorasanizadeh, and F. Rastinejad. 2003. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol. Cell 11:1093-1100.
27. Moir, A., and D. A. Smith. 1990. The genetics of bacterial spore germination. Annu. Rev. Microbiol. 44:531-553.
28. Nagengast, F. M., M. J. Grubben, and I. P. van Munster. 1995. Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer 31A:1067-1070.
29. Nobilis, M., M. Pour, J. Kunes, J. Kopecky, J. Kvetina, Z. Svoboda, K. Sladkova, and J. Vortel. 2001. High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization. J. Pharm. Biomed. Anal. 24:937-946.
30. Northfield, T., and I. McColl. 1973. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut 14:513-518.
31. O'Brien, J. A., B. J. Lahue, J. J. Caro, and D. M. Davidson. 2007. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28:1219-1227.
32. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, and J. M. Lehmann. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
33. Poutanen, S. M., and A. E. Simor. 2004. Clostridium difficile-associated diarrhea in adults. CMAJ 171:51-58.
34. Qin, J., R. Li, J. Raes, M. Arumugam, K. S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, T. Yamada, D. R. Mende, J. Li, J. Xu, S. Li, D. Li, J. Cao, B. Wang, H. Liang, H. Zheng, Y. Xie, J. Tap, P. Lepage, M. Bertalan, J.-M. Batto, T. Hansen, D. Le Paslier, A. Linneberg, H. B. Nielsen, E. Pelletier, P. Renault, T. Sicheritz-Ponten, K. Turner, H. Zhu, C. Yu, S. Li, M. Jian, Y. Zhou, Y. Li, X. Zhang, S. Li, N. Qin, H. Yang, J. Wang, S. Brunak, J. Dore, F. Guarner, K. Kristiansen, O. Pedersen, J. Parkhill, J. Weissenbach, P. Bork, S. D. Ehrlich, and J. Wang. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65.
35. Raibaud, P., R. Ducluzeau, F. Dubos, S. Hudault, H. Bewa, and M. C. Muller. 1980. Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice. Am. J. Clin. Nutr. 33:2440-2447.
36. Ramirez, N., and E. Abel-Santos. 2010. Requirements for germination of Clostridium sordellii spores in vitro. J. Bacteriol. 192:418-425.
37. Ramirez, N., M. Liggins, and E. Abel-Santos. 2010. Kinetic evidence for the presence of putative germination receptors in C. difficile spores. J. Bacteriol. 192:4215-4222.
38. Reddy, B. S. 1975. Role of bile metabolites in colon carcinogenesis. Animal models. Cancer 36:2401-2406.
39. Redelings, M. D., F. Sorvillo, and L. Mascola. 2007. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13:1417-1419.
40. Ridlon, J. M., D. Kang, and P. B. Hylemon. 2006. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47:241-259.
41. Samuel, P., C. M. Holtzman, E. Meilman, and I. Sekowski. 1973. Effect of neomycin and other antibiotics on serum cholesterol levels and on 7α-dehydroxylation of bile acids by the fecal bacterial flora in man. Circ. Res. 33:393-402.
42. Sebaihia, M., B. W. Wren, P. Mullany, N. F. Fairweather, N. Minton, R. Stabler, N. R. Thomson, A. P. Roberts, A. M. Cerdeno-Tarraga, H. Wang, M. T. G. Holden, A. Wright, C. Churcher, M. A. Quail, S. Baker, N. Bason, K. Brooks, T. Chillingworth, A. Cronin, P. Davis, L. Dowd, A. Fraser, T. Feltwell, Z. Hance, S. Holroyd, K. Jagels, S. Moule, K. Mungall, C. Price, E. Rabbinowitsch, S. Sharp, M. Simmonds, K. Stevens, L. Unwin, S. Whithead, B. Dupuy, G. Dougan, B. Barrell, and J. Parkhill. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
43. Setlow, P. 2003. Spore germination. Curr. Opin. Microbiol. 6:550-556.
44. Songer, J. G., and M. A. Anderson. 2006. Clostridium difficile: an important pathogen of food animals. Anaerobe 12:1-4.
45. Sorg, J. A., and A. L. Sonenshein. 2008. Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190:2505-2512.
46. Sorg, J. A., and A. L. Sonenshein. 2009. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J. Bacteriol. 191:1115-1117.
47. Tochtrop, G. P., K. Richter, C. Tang, J. J. Toner, D. F. Covey, and D. P. Cistola. 2002. Energetics by NMR: site-specific binding in a positively cooperative system. Proc. Natl. Acad. Sci. U. S. A. 99:1847-1852.
48. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
49. Weese, J. S., H. R. Staempfli, and J. F. Prescott. 2000. Isolation of environmental Clostridium difficile from a veterinary teaching hospital. J. Vet. Diagn. Investig. 12:449-452.
50. White, B. A., R. L. Lipsky, R. J. Fricke, and P. B. Hylemon. 1980. Bile acid induction specificity of 7-alpha-dehydroxylase activity in an intestinal Eubacterium species. Steroids 35:103-109.
51. Wilson, K. H. 1983. Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J. Clin. Microbiol. 18:1017-1019.
52. Wilson, K. H., M. J. Kennedy, and F. R. Fekety. 1982. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J. Clin. Microbiol. 15:443-446.
53. Wilson, K. H., and F. Perini. 1988. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect. Immun. 56:2610-2614.
54. Zar, F., S. Bakkanagari, K. M. L. S. T. Moorthi, and M. Davis. 2007. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. 45:302-307.